CDKN2A and neoplasm: Using SCT cells, which are derived from the skin of p16Ink4a knockout mice and are highly expressing CX3CL1, we showed that treatment with anti-CX3CL1 exerted significant suppressive effects against tumour progression, which has not been previously demonstrated in vivo (Fig. 4g).